Innovative Research Award
Bamidele Iwalokun — Nigerian Institute of Medical Research, Nigeria
Bamidele Iwalokun is a Nigerian biomedical researcher affiliated with the Nigerian Institute of Medical Research, where the supplied ORCID record identifies his employment as Head of Molecular Biology & Biotechnology. The same record identifies doctoral training in Biochemistry and documents a substantial body of scholarly works spanning molecular biology, infectious diseases, antimicrobial resistance, genomics and computational vaccine research. [1]
Abstract
Bamidele Iwalokun’s documented research profile encompasses molecular biology, biotechnology, infectious disease research, antimicrobial resistance, genomics and immunoinformatics. His publication record includes computational investigations of vaccine candidates and mRNA vaccine design, alongside laboratory and epidemiological studies of infectious diseases. The ORCID record supplied for this article documents multiple recent publications with established journal and DOI information. [2] [3]
Keywords
Immunoinformatics; vaccine design; mRNA vaccines; epitope-based vaccines; molecular biology; biotechnology; infectious diseases; antimicrobial resistance; genomics; computational biology; pharmaceutical research; vaccine development; biomedical innovation.
Introduction
Immunoinformatics applies computational methods to immunological data and is increasingly used to support the identification and evaluation of vaccine targets, epitopes and antigenic features. Such approaches can help organize complex biological information before experimental validation and may contribute to more systematic vaccine-development workflows. Iwalokun’s documented publications include several studies explicitly describing immunoinformatics-based approaches to vaccine design. [2]
Research Profile
His documented research profile intersects molecular biology, biotechnology, infectious disease microbiology and computational approaches to vaccine development. In particular, publications from 2024 describe immunoinformatics applications to Mokola virus, vaccinia and Mpox viruses, Epstein–Barr virus and hepatitis E virus. These works provide direct evidence for the relevance of immunoinformatics within his broader research portfolio. [2]
Research Contributions
The wider publication record includes research on multidrug-resistant organisms, resistance-associated genes, whole-genome sequencing and pathogen characterization. Examples include studies of methicillin-resistant Staphylococcus aureus, carbapenemase-producing Pseudomonas aeruginosa, multidrug-resistant Escherichia coli and molecular characteristics of other clinically important organisms. These investigations complement the computational research by addressing biological and microbiological questions relevant to infectious disease control. [5] [6]
Publications
The supplied ORCID record lists numerous scholarly works associated with Bamidele Iwalokun. Recent publications include research on infection prevention and control among healthcare workers in Nigerian COVID-19 treatment centres, the molecular landscape of methicillin-resistant Staphylococcus aureus, and computational vaccine-related studies. The record also identifies DOI information for these publications, providing persistent identifiers for scholarly verification.[4]
Research Impact
Beyond bibliometric indicators, the research record demonstrates activity across several interconnected biomedical themes. The combination of computational vaccine design, molecular characterization, antimicrobial resistance research and infectious disease studies provides a multidisciplinary foundation. This breadth may be particularly relevant to research recognition programs that consider methodological innovation and contribution to pharmaceutical or biomedical science. [1] [2]
Award Suitability
The documented research profile is substantively aligned with an Innovative Research Award because it contains peer-reviewed work applying computational and molecular approaches to contemporary vaccine-development questions. The immunoinformatics publications provide direct evidence of innovation-oriented research activity, particularly through computational vaccine design and epitope-based strategies. [4]
Conclusion
Bamidele Iwalokun’s documented scholarly profile represents a multidisciplinary research portfolio spanning molecular biology, biotechnology, infectious diseases, antimicrobial resistance and immunoinformatics. The combination of computational vaccine research and molecular infectious disease research provides a strong scholarly basis for considering the profile in the context of innovative pharmaceutical and biomedical research. The available publication evidence supports a neutral assessment of substantial research activity in areas that intersect immunoinformatics, vaccine development and translational biomedical science.[4]
External Links
References
- ORCID. (2026). Bamidele Iwalokun — ORCID record. ORCID.
https://orcid.org/0000-0003-4247-2797
- Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Omole, T. O., Adeyemo, S. F., Irewolede, B. A., Iwalokun, B. A., Ajani, O. F., & Onyeaka, H. (2024). Bioinformatics designing of an mRNA vaccine for Mokola virus (MOKV) using immunoinformatics as a secure strategy for successful vaccine development. BMC Immunology.
https://doi.org/10.1186/s12865-024-00668-2
- Oladipo, E. K., Oyelakin, O. D., Aiyelabegan, A. O., Olajide, E. O., Olatayo, V. O., Owolabi, K. P., Shittu, Y. B., Olugbodi, R. O., Ajala, H. A., et al. (2024). Exploring computational approaches to design mRNA vaccine against vaccinia and Mpox viruses. Immunity, Inflammation and Disease.
https://doi.org/10.1002/iid3.1360
- Oladipo, E. K., Dairo, E. O., Bamigboye, C. O., Ajayi, A. F., Onile, O. S., Ariyo, O. E., Jimah, E. M., Oyawoye, O. M., Oloke, J. K., Iwalokun, B. A., et al. (2024). Harnessing immunoinformatics for precision vaccines: Designing epitope-based subunit vaccines against hepatitis E virus. BioMedInformatics, 4(3), 88.
https://doi.org/10.3390/biomedinformatics4030088
- Olalekan, A., Bader, B. K., Iwalokun, B., Wolf, S., Lalremruata, A., Dike, A., Mannie-Udoh, M., Lo Presti, L., Liese, J., Guther, J., et al. (2023). High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria. JAC-Antimicrobial Resistance.
https://doi.org/10.1093/jacamr/dlad038